The Past, Present and Future of Genome Sequencing
The last two decades have seen a revolution in genome sequencing with dramatic increases in…
The last two decades have seen a revolution in genome sequencing with dramatic increases in…
The next generation of DNA sequencers has arrived, and with it, a clash of titans:…
Update (30/01/2018): Oxford Nanopore has published a study in Nature Biotechnology outlining the first use of…
DNA Script has gathered the support of key international investors to take a new, faster…
Illumina has launched its NGS-based non-invasive prenatal test (NIPT) in Europe and is ready to…
Access to data is still the main bottleneck for genomic researchers. Repositive has created a…
Illumina's cancer diagnostics baby, GRAIL, has raked in a jaw-dropping $1B in Series B. Should…
Despite a lawsuit from Illumina, Premaitha forged ahead with its NGS-based non-invasive prenatal test; the…
The problem with CRISPR, is that not many people are actually experts in the field,…
Genoma is being sued by Illumina over four patents covering technology for prenatal testing, that…
NGS-Giant Illumina (US) is suing Oxford Nanopore (UK), the Unicorn ready to disrupt gene sequencing.…
Genomics England (UK) today announce a partnership with the Next-Generation Sequencing Giant, Illumina (US), to develop a…